MOTOCEF-CV-375
MRP: 3,200
Packaging: 10x10
Pack Type: tablet
Composition:
Cefuroxime 250mg + Clavulanic Acid 125mg
Indication:
Pharyngitis & Tonsillitis, Skin & Soft Tissue Infection, Pneumonia & Bronchitis, Post Surgical Conditions.
Description:
Cefuroxime 250 mg + Clavulanic Acid 125 mg combines the cephalosporin antibiotic Cefuroxime with Clavulanic Acid, a beta-lactamase inhibitor. This combination provides enhanced effectiveness by protecting Cefuroxime from bacterial enzymes that would otherwise degrade it.
Cefuroxime is a second-generation cephalosporin with broad-spectrum activity against Gram-positive and Gram-negative bacteria. Clavulanic acid helps extend its action by preventing resistance mechanisms in bacteria, making this combination particularly useful for treating infections caused by resistant strains.
This formulation is commonly used to treat respiratory infections, urinary tract infections, skin and soft tissue infections, sinusitis, and bacterial pneumonia.
Tags:
- Broad-spectrum action against a wide range of bacteria
- Helps combat bacterial resistance with the inclusion of Clavulanic acid
- Convenient oral formulation for easy administration
- Effective for treating respiratory, skin, and urinary tract infections
- Suitable for infections caused by beta-lactamase-producing bacteria
Usage Information
Dosage
Adults: Typically, 1 tablet (250 mg + 125 mg) every 12 hours Duration: 7–10 days or as prescribed by a doctor Take with food to reduce gastrointestinal upset and improve absorption Do not stop the treatment early, even if symptoms improve, to avoid recurrence of the infection
Side Effects
Common: Nausea, diarrhea, mild stomach upset Less common: Headache, dizziness, rash Serious (seek medical attention): Severe allergic reaction, jaundice, severe diarrhea (possible Clostridium difficile infection) Rare: Liver enzyme elevation, abnormal blood counts
Contraindications
Allergy to cephalosporins, penicillins, or any components of this product Severe allergic reactions to antibiotics (e.g., anaphylaxis) Use with caution in patients with renal impairment History of liver disease (monitor liver function during treatment) Not recommended for newborns under 2 months old Colitis or other gastrointestinal disorders may require caution